Brief Use of CGM May Enhance Lifestyle Awareness in T2D
TOPLINE:
Short-term use of continuous glucose monitoring (CGM) provided valuable insights into lifestyle factors affecting blood glucose levels in people with type 2 diabetes (T2D) who were not on insulin therapy, particularly in those with a diabetes duration of less than 5 years.
METHODOLOGY:
CGM is an effective strategy for managing blood glucose levels in people with non-insulin-treated T2D; this study focused on the insights gained regarding lifestyle factors affecting blood glucose levels over a 2-week period of usage.
Participants with non-insulin-treated T2D across 20 cities in Denmark received a single CGM device during a walk-in setup, with minimal guidance provided during device installation.
They used the CGM device for a maximum of 14 days.
Baseline questionnaires were completed onsite, with follow-up surveys sent via email after 2 weeks and after 3 months.
TAKEAWAY:
A total of 724 participants completed the second questionnaire sent after 2 weeks.
Of these, 80% found CGM highly useful and informative for managing T2D.
Participants with a diabetes duration of less than 5 years engaged in more daily scans (80% vs 71%) and reported greater insights into the effects of lifestyle on glucose levels — including food (88% vs 78%), portion sizes (80% vs 60%), and physical activity (65% vs 55%) — than those with a diabetes duration of more than 5 years.
Education level did not significantly affect the knowledge gained from CGM usage.
At the 3-month follow-up, 50% of participants reported maintaining behavioral changes based on their CGM experience.
IN PRACTICE:
"These insights may encourage long-term behavioral changes, potentially leading to improved glycemic control," the authors wrote.
SOURCE:
The study was led by Emma Munch Nielsen, Glostrup, Denmark. It was presented by Tanja Thybo, Glostrup, Denmark, on June 20, 2025, at the 85th Scientific Sessions - American Diabetes Association, held at the McCormick Place Convention Center, Chicago.
LIMITATIONS:
No limitations were discussed in the abstract.
DISCLOSURES:
No funding details were disclosed. Three authors disclosed relationships with Abbott.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
35 minutes ago
- Yahoo
With rising temperatures in North Carolina, hospitals report uptick of snake bites
CARY, N.C. (WNCN) — Hospitals throughout the central North Carolina said they're seeing more patients with snake bites walking through their doors. Raleigh native Anita McLoud went through the whole experience when she was bitten by a copperhead in her backyard. She never imagined she'd find herself calling 911 in the hospital, and with a venomous bite. After checking on her chickens during a night in August, McLoud said she turned around to walk back to her house when she had a startling surprise. 'One of the first two things I remember learning from my mom is how to identify a copperhead and how to identify poison ivy,' McLoud said. 'Those were the things you needed to know going out of the house. 'I was in my backyard,' she said. 'I had not seen a snake there in 23 years that I lived there and I was wearing flip flops.' 'My first thought was it's a stick. Within a split second, I [realized] that was not a stick. Was it a snake? I turned and there he was.' According to McLoud, medical staff measured the swelling near the bite every 30 minutes. While she never needed antivenom, doctors gave her morphine for the pain. She said the swelling, pain, and discoloration lasted around five-six weeks. 'I was fortunate that way,' McLoud said. 'They told me at the time, only 23% of people who got bit had to receive the antivenom.' According to Duke Health officials, hospitals usually see more than 100 snakebite patients per year across the health system, with the number of cases typically peaking in July. Since April, officials said emergency departments at Duke University, Duke Regional Hospital and Raleigh Regional Hospital have treated 22 bites this season, which staff said typically starts in April. Officials at WakeMed said an emergency department reported nine patients since June 1, six just between June 14 and June 17. Last year, they saw an increase from 15 patients treated for bites in June to 40 in July. UNC Hospitals in Chapel Hill reported 18 patients from March to mid-June, slightly higher than the same time last year. 'The numbers increase as the weather gets warmer, especially when it's hot and more of us work/play in the yard early in the morning or in the evening—when snakes get more active, too,' staff said in a statement. Talena Chavis of Cary, the owner of NC Snake Catcher has studied snakes for nearly 30 years. She said the summer season typically comes with 8-10 calls a day, often to safely move and relocate snakes. 'I actually don't encourage folks to try to ID snakes themselves because Mother Nature throws curveballs,' Chavis said. 'Even with copperheads, the pattern changes a lot.' North Carolina has six venomous snakes. According to Chavis, the copperhead's bite is rarely fatal. 'Every season, copperheads are our number one snake,' Chavis said. 'To say that we have a surplus or even an overpopulation is not is not off topic.' Chavis believes more encounters have been attributed to more growth and development. The species has also adapted to urban and suburban areas. 'They're not really afraid of loud noises,' she said. 'They don't care about fireworks, blowers, lawnmowers. These guys just don't really care because they're an ambush predator.' According to Chavis, most bites happen during night hours when copperheads are searching for heat and their prey. Most the time, she said people just happen to get in the way. Chavis advises people to be more cautious, aware, and put on boots. 'I firmly believe if people wore their boots in the yard and watched where they put their hands, the number of copperhead bites would be cut in half,' she said. Even after her encounter, McLoud said she now works with the reptiles. 'I've really been enjoying it,' McLoud said. 'I wasn't upset with the snake. He's just doing his 'self-defense' thing. If someone stepped on me, I'd probably react as well.' Duke Health officials also continue to share more information about snakebite safety. If bitten, they said to go to your local hospital—never push off the visit. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
2 hours ago
- Yahoo
Venuiti Healthcare aids healthcare compliance with Conformance Testing Suite
Canadian technology company Venuiti Healthcare, in collaboration with Amplify Care, has introduced a Conformance Testing Suite, which aims to assist caregivers and software vendors in maintaining compliance with health information standards. This initiative marks a step towards streamlining the digital transformation of patient care in Canada. The Conformance Testing Suite addresses the increasing complexity of healthcare standards at provincial, national, and jurisdictional levels. The platform enables organisations to remain compliant without compromising operational efficiency, ensuring that healthcare systems across the country advance in unison. Venuiti director Jordan Schroecker said: 'As two Canadian companies deeply invested in the future of our healthcare system, we designed this to give healthcare professionals exactly what they need: clear insights, actionable outcomes, and the confidence to modernise while staying aligned.' Care givers benefit from the suite's features, including downloadable, audit-ready reports, a complete history of testing and modifications, and detailed insights at the code level. These tools enable IT teams, compliance leaders, and clinical decision-makers to take decisive, informed actions promptly, eliminating uncertainty and delays. Venuiti chief technology officer Alexey Sidelnikov said: 'By turning regulatory complexity into clear, testable outputs—right down to the lines of code—we're giving them the ability to move fast, stay aligned, and focus more energy on delivering care.' Curated to the real-world demands of adhering to health information standards, the suite ensures that software solutions used by healthcare professionals can interoperate effectively, scale systems, and adapt to changing mandates while enhancing the quality of care delivery. Venuiti specialises in custom software and digital transformation solutions for the healthcare sector. Previously known as the eHealth Centre of Excellence, Amplify Care champions clinicians by amplifying their voices and facilitating the adoption of digital health solutions that reduce workloads and enhance clinicians' workflows. "Venuiti Healthcare aids healthcare compliance with Conformance Testing Suite" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
PharmaSens and SiBionics to develop wearable insulin patch pump
Swiss company PharmaSens and SiBionics have entered a development partnership for niia signature, an all-in-one wearable that integrates the delivery of insulin with continuous glucose monitoring (CGM) into a compact pump. Through this device, the parties anticipate simplifying the management of diabetes for individuals who utilise insulin, aiming to minimise the daily therapy load. The wearable will leverage PharmaSens' patented platform technologies along with the biosensor capabilities of SiBionics. Both companies will offer their engineering and development know-how to bring this patch pump to the market. PharmaSens CEO Marcel Both said: 'This partnership marks a significant milestone toward realising our vision of a fully integrated, discreet, and intuitive insulin-therapy system. 'SiBionics' proven expertise in sensor technology is a perfect complement to our platform.' PharmaSens is currently developing a portfolio of three insulin patch pumps, including niia signature, designed to cater to a broad range of user needs. The range begins with the niia essential, a basal-bolus insulin pump that prioritises ease of use by minimising complexity. The niia advanced provides additional options and can be controlled through a smartphone, also allowing connection to an external CGM. PharmaSens highlights that its devices consist of one reusable part, comprising the pump and CGM electronics with a two-year lifespan, and one disposable part, which includes a 3ml insulin reservoir to extend wear time and reduce insulin waste. The company is focused on simplifying diabetes management and expanding access to insulin pump therapy. Founded in 2015, CGM technology provider SiBionics brings to the partnership its core expertise in medical device research and development, with offices in China and the US. Last year, PharmaSens submitted an application to the US Food and Drug Administration (FDA) for approval of its niia essential insulin patch pump system. "PharmaSens and SiBionics to develop wearable insulin patch pump" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
